The Outlier in All of Us: Why Implementing Pharmacogenomics Could Matter for Everyone.
Clin Pharmacol Ther. 2016 Apr;99(4):401-4.
O'Donnell PH, Danahey K, Ratain MJ.
Pharmacogenomics in the clinic.
Nature. 2015 Oct 15;526(7573):343-50.
Relling MV, Evans WE.
Preemptive clinical pharmacogenetics implementation: current programs in five US medical centers.
Annu Rev Pharmacol Toxicol. 2015;55:89-106.
Dunnenberger HM, Crews KR, Hoffman JM, Caudle KE, Broeckel U, Howard SC, Hunkler RJ, Klein TE, Evans WE, Relling MV.
The Affymetrix DMET platform and pharmacogenetics in drug development.
Curr Opin Mol Ther. 2009 Jun;11(3):260-8.
Deeken J.
Characterization of 137 Genomic DNA Reference Materials for 28 Pharmacogenetic Genes: A GeT-RM Collaborative Project.
J Mol Diagn. 2016 Jan;18(1):109-23. doi: 10.1016/j.jmoldx.2015.08.005. Epub 2015 Nov 24.
Pratt VM, Everts RE, Aggarwal P, Beyer BN, Broeckel U, Epstein-Baak R, Hujsak P, Kornreich R6, Liao J, Lorier R, Scott SA, Smith CH5, Toji LH, Turner A, Kalman LV.
Pharmacogenetics for Safe Codeine Use in Sickle Cell Disease.
Pediatrics. 2016 Jul;138(1).
Gammal RS, Crews KR, Haidar CE, Hoffman JM, Baker DK, Barker PJ, Estepp JH, Pei D, Broeckel U, Wang W, Weiss MJ, Relling MV, Hankins J.
PG4KDS: a model for the clinical implementation of pre-emptive pharmacogenetics.
Am J Med Genet C Semin Med Genet. 2014 Mar;166C(1):45-55.
Hoffman JM, Haidar CE, Wilkinson MR, Crews KR, Baker DK, Kornegay NM, Yang W, Pui CH, Reiss UM, Gaur AH, Howard SC, Evans WE, Broeckel U, Relling MV.
Development and use of active clinical decision support for preemptive pharmacogenomics.
J Am Med Inform Assoc. 2014 Feb;21(e1):e93-9.
Bell GC, Crews KR, Wilkinson MR, Haidar CE, Hicks JK, Baker DK, Kornegay NM, Yang W, Cross SJ, Howard SC, Freimuth RR, Evans WE, Broeckel U, Relling MV, Hoffman JM.
The Pharmacogenomics Research Network Translational Pharmacogenetics Program: overcoming challenges of real-world implementation.
Clin Pharmacol Ther. 2013 Aug;94(2):207-10.
Shuldiner AR, Relling MV, Peterson JF, Hicks JK, Freimuth RR, Sadee W, Pereira NL, Roden DM, Johnson JA, Klein TE;
Concordance of DMET plus genotyping results with those of orthogonal genotyping methods.
Clin Pharmacol Ther. 2012 Sep;92(3):360-5.
Fernandez CA, Smith C, Yang W, Lorier R, Crews KR, Kornegay N, Hicks JK, Stewart CF, Kawedia JD, Ramsey LB, Liu C, Evans WE, Relling MV, Broeckel U.
A clinician-driven automated system for integration of pharmacogenetic interpretations into an electronic medical record.
Clin Pharmacol Ther. 2012 Nov;92(5):563-6.
Hicks JK, Crews KR, Hoffman JM, Kornegay NM, Wilkinson MR, Lorier R, Stoddard A, Yang W, Smith C, Fernandez CA, Cross SJ, Haidar C, Baker DK, Howard SC, Evans WE, Broeckel U, Relling MV.
Pharmacogenetic allele nomenclature: International workgroup recommendations for test result reporting.
Clin Pharmacol Ther. 2016 Feb;99(2):172-85.
Kalman LV, Agúndez J, Appell ML, Black JL, Bell GC5, Boukouvala S, Bruckner C, Bruford E, Caudle K, Coulthard SA, Daly AK, Del Tredici A, den Dunnen JT, Drozda K, Everts RE, Flockhart D, Freimuth RR, [...et.al.].
Pharmacogenomics: challenges and opportunities.
Ann Intern Med. 2006 Nov 21;145(10):749-57.
Roden DM, Altman RB, Benowitz NL, Flockhart DA, Giacomini KM, Johnson JA, Krauss RM, McLeod HL, Ratain MJ, Relling MV, Ring HZ, Shuldiner AR, Weinshilboum RM, Weiss ST; Pharmacogenetics Research Network.
